Interstitial lung diseases (ILD) encompass a diverse group of pulmonary conditions characterized by inflammation and fibrosis of the lung interstitium. This article provides a comprehensive overview of ILD, focusing on its etiology, classification, clinical presentation, diagnosis, and management.
ILDs can be idiopathic or secondary to various factors such as occupational exposure, drugs, and systemic diseases. Based on etiology, ILDs are classified into idiopathic interstitial pneumonias, connective tissue disease-associated ILD, and occupational ILD, among others.
Patients with ILD typically present with progressive dyspnea and non-productive cough. Physical examination may reveal inspiratory crackles and finger clubbing. Hypoxemia and restrictive pattern are common findings on arterial blood gas analysis and pulmonary function tests respectively.
High-resolution computed tomography (HRCT) is the imaging modality of choice for ILD. It helps in identifying the pattern of disease which can be either usual interstitial pneumonia (UIP) or non-specific interstitial pneumonia (NSIP). Bronchoalveolar lavage and lung biopsy may be required in certain cases for definitive diagnosis.
Management of ILD is largely based on the underlying cause. In idiopathic cases, treatment is primarily supportive, including oxygen therapy and pulmonary rehabilitation. Immunosuppressive therapy may be used in cases associated with connective tissue diseases. Lung transplantation may be considered in advanced cases.
In conclusion, ILD represents a complex group of lung disorders with diverse etiology and clinical presentation. High clinical suspicion, coupled with appropriate diagnostic modalities, is key to timely diagnosis and management. As healthcare professionals, understanding the nuances of ILD is crucial for providing optimal patient care.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation